Mereo BioPharma Group plc (MREO) P/S ratio

P/S ratio today
87.5×

Only 2 fiscal years of P/S ratio are on record here for Mereo BioPharma Group plc (MREO); a history needs at least 3. Mereo BioPharma Group plc (MREO) trades at 87.5× its revenue per share for fiscal 2025. Figures as of 18 Nov 2026, 10:32 UTC, from Yahoo Finance.

Key facts

P/S ratio today
87.5×
P/S ratio, fiscal 2025
133.0×
Fiscal years on record
22023–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/S ratio needs at least 3 fiscal years; 2 are on record here for Mereo BioPharma Group plc. Nothing is estimated to fill the gap. What is on record is in the table below.

Mereo BioPharma Group plc P/S ratio, year by year

Mereo BioPharma Group plc (MREO) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today87.5×—$0.27—
2025133.0×—$0.42$0.00
2024——$3.50—
202330.5×—$2.31$0.08
2022——$0.75—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on MREO

Mereo BioPharma Group plc, figure by figure

Mereo BioPharma Group plc (MREO) overview: price, valuation and scorecard

Mereo BioPharma Group plc P/S ratio: questions and answers

What is Mereo BioPharma Group plc's P/S ratio?

Mereo BioPharma Group plc (MREO) trades at 87.5× its revenue per share for fiscal 2025.

How is Mereo BioPharma Group plc's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Mereo BioPharma Group plc it is on record here for 2 fiscal years, 2023 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Mereo BioPharma Group plc (MREO) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/MREO/ps-ratio

Underlying data: Yahoo Finance.